In the SURMOUNT-1 trial, tirzepatide at 15 mg achieved a mean weight reduction of 20.9%, approximately 6 percentage points above semaglutide's best result in comparable populations
Where each stands and what the data shows The reported results put them in a rough order on efficacy, though cross-trial comparisons are not definitive
Heavy use can damage the liver over time, which can make clotting and medication effects harder to manage (CDC, 2025b)
Int J Mol Sci 25(23):13042 Ghosal J, Sinchana VK, Chakrabarty S (2025) Ferroptosis meets microRNAs: a new frontier in anti-cancer therapy
Enhances skin elasticity and boosts natural radiance
True recovery depends on sleep consistency, nutrition, nervous system regulation, movement, hydration, mental health care, hormone balance, and stress reduction